Wow, it is very suprised to see IBX still stay with a $74 market cap after one year, imo it is still overvalued. Covid is not an excuse, it has been a year. IBX can not even have patients to start clinical trail while the other biotech company has been granted approval like TLX. BTW, TLX has similar diagnosis technology. So I do not believe IBX is that special！ It was just pumped significantly by some chinese pumpers last year. $1 by the end of 2021, $2 by the end of 2022? what a joke!! what an opportunity cost! You could have got Disallowed by switching to Lithium stock...LOL. IMO, 0.03 is coming..... do not believe? have a look at the chart for 2017-2019.
IBX Price at posting:
6.6¢ Sentiment: Sell Disclosure: Not Held
